Table 2.
Both groups (N = 138) |
MDD group (N = 80) |
||||||||
---|---|---|---|---|---|---|---|---|---|
df | F | p | ηp2 | df | F | p | ηp2 | ||
NR3C1 | |||||||||
CpG12 | 1, 116 | 1.033 | 0.312 | 0.009 | 1, 63 | 0.143 | 0.706 | 0.002 | |
CpG20 | 1, 117 | 0.859 | 0.356 | 0.007 | 1, 63 | 2.294 | 0.135 | 0.035 | |
Amplicon 1 (CpG9-21) | 1, 117 | 0.649 | 0.422 | 0.006 | 1, 63 | 0.716 | 0.401 | 0.011 | |
Amplicon 4 (CpG40-47) | 1, 119 | 1.039 | 0.310 | 0.009 | 1, 65 | 0.002 | 0.968 | 0.000 | |
Total average | 1, 119 | 0.907 | 0.343 | 0.008 | 1, 65 | 5.451 | 0.023* | 0.077 | |
SLC6A4 | |||||||||
CpG8 | 1, 118 | 0.004 | 0.952 | 0.000 | 1, 65 | 0.007 | 0.936 | 0.000 | |
CpG10 | 1, 118 | 4.081 | 0.046* | 0.033 | 1, 65 | 2.873 | 0.095 | 0.042 | |
Amplicon 1 (CpG8-12) | 1, 118 | 6.963 | 0.010* | 0.056 | 1, 65 | 5.180 | 0.026* | 0.074 |